Merck signs $5.5 billion deal with Daiichi for cancer therapy development
TOKYO (Reuters) -Japan's Daiichi Sankyo announced on Friday a $5.5 billion agreement with Merck to jointly develop its three precision
2023-10-20 09:23
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Moderna said on Wednesday it has begun enrolling patients in a late-stage study evaluating its personalised mRNA-based skin
2023-07-26 20:18
Merck sues US government to halt Medicare drug price negotiation
By Michael Erman NEW YORK (Reuters) -Merck & Co sued the U.S. government on Tuesday, seeking an injunction of the
2023-06-06 21:22
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
By Julie Steenhuysen CHICAGO Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the
2023-06-05 20:18
Germany's Merck flags decline in operating profit of up to 10% in 2023
By Ludwig Burger FRANKFURT Germany's Merck KGaA on Thursday warned that adjusted operating earnings could decline by as
2023-05-11 13:54